Hengrui Pharma shares surge on $1 bln Bristol-Myers partnership

Chronological Source Flow
Back

AI Fusion Summary

Shares of Hengrui Pharma jumped after announcing a $1 billion partnership with Bristol‑Myers Squibb, which also signed an up to $15 billion licensing deal. The collaboration expands Hengrui’s global reach and strengthens its portfolio.
Community Comments
Loading updates...
0